New research reveals a statistical technique used in Alzheimer's drug trials inflates clinical efficacy claims by 29x.

A statistical approach being used to support a new class of Alzheimer's drugs may lead to overstated claims about how the drugs work, according to a new study led by researchers at the Brown ...

India, May 19 -- Reducing amyloid buildup in the brain may not improve cognition as strongly as some Alzheimer's drug ...

Fuzzy aggregation methods form a cornerstone of contemporary classification systems by enabling the combination of imprecise, overlapping or partially true information into coherent decisions. At ...